Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2026-02-27 @ 10:38 AM
Study NCT ID:
NCT02343406
Status:
COMPLETED
Last Update Posted:
2020-05-22
First Post:
2014-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-22
First Submit QC Date:
None
Study First Post Date:
2015-01-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-30
Results First Submit QC Date:
None
Results First Post Date:
2020-05-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-08
Last Update Post Date:
2020-05-22
Last Update Post Date Type:
ACTUAL